About 5 results found for searched term "93-89-0" (0.057 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2099 | OSI-027 | mTOR |
| OSI-027 is an orally bioavailable, potent and selective inhibitor of mTORC1 and mTORC2 with IC50 values of 22 nM and 65 nM, respectively. | ||
| M10393 | Eribulin mesylate | Microtubule |
| B1939 mesylate; E7389 mesylate; ER-086526 mesylate | ||
| Eribulin mesylate (E7389 mesylate) is a microtubule targeting agent that is used for the research of metastatic breast cancer. | ||
| M44286 | Ethyl benzoate | Others |
| Ethyl benzoate | ||
| M51663 | [Ac-Tyr1, D-Phe2]GRF 1-29, amide (human) | Others |
| [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human), a growth hormone releasing factor (GRF) analogue, is a vasoactive intestinal peptide (VIP) antagonist. | ||
| M55624 | BN-104 | Epigenetic Reader Domain |
| BNM-1192; Menin-MLL inhibitor 27 | ||
| BN-104 (BNM-1192) is a novel, potent and highly selective, oral menin inhibitor. BN-104 (BNM-1192) can inhibit the Menin-MLL interaction. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
